Table 1.
Participant characteristics and baseline measurements
| Variable | All Participants (n = 14) | Male (n = 8) | Female (n = 6) |
|---|---|---|---|
| Age (years) | 31 ± 6 | 30 ± 6 | 33 ± 6 |
| Height (m) | 1.71 ± 0.12 | 1.80 ± 0.45 | 1.60 ± 0.79 *** |
| Weight (kg) | 78.45 ± 24.72 | 95.19 ± 18.98 | 56.13 ± 6.21 *** |
| FM (%) | 17.47 ± 3.99 | 17.57 ± 4.81 | 17.33 ± 3.01 |
| FM (kg) | 14.13 ± 7.48 | 17.39 ± 8.49 | 9.78 ± 2.22 |
| FFM (%) | 82.53 ± 3.99 | 82.43 ± 4.81 | 82.67 ± 3.01 |
| FFM (kg) | 64.32 ± 18.42 | 77.79 ± 11.36 | 46.36 ± 4.86 *** |
| PhA (°) | 8.19 ± 0.74 | 8.55 ± 0.37 | 7.72 ± 0.88 * |
| Squat 1RM (kg) | 132.50 ± 53.67 | 167.19 ± 41.18 | 86.25 ± 24.99 *** |
| Bench Press 1RM (kg) | 92.32 ± 43.16 | 124.38 ± 21.91 | 49.58 ± 18.33 *** |
| Row 1RM (kg) | 85.71 ± 34.74 | 113.75 ± 11.26 | 48.33 ± 5.16 *** |
| CK (U.L−1) | 172.92 ± 106.86 | 245.14 ± 92.59 | 88.67 ± 36.01 ** |
| TNF-α (pg.mL−1) | 1.54 ± 0.28 | 1.59 ± 0.26 | 1.47 ± 0.31 |
Outlines participant characteristics and baseline assessment measures. Reference to gender differences are also included to demonstrate adherence to inclusion criteria. Data are presented as M ± SD
FM Fat Mass, FFM Fat Free Mass, PhA Phase angle, RM repetition maximum, CK Creatine Kinase, TNF-α Tumor Necrosis Factor-α
Significant gender differences denoted as: *p = 0.03; **p = 0.003; ***p ≤ 0.001